Raymond James Financial Services Advisors, Inc. Emergent Bio Solutions Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$56.61 - $80.46 $336,999 - $478,978	-5,953 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $164,613 - $238,987	-1,909 Reduced 24.28%	5,953 $553,000
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $507,796 - $714,968	-6,414 Reduced 44.93%	7,862 $704,000
Q3 2020 Nov 04, 2020	BUY	$81.91 - $134.94 $852,846 - $1.4 Million	10,412 Added 269.46%	14,276 $1.48 Million
Q2 2020 Jul 17, 2020	BUY	$54.33 - $89.52 $209,931 - $345,905	3,864 New	3,864 $306,000

Others Institutions Holding EBS

# of Institutions

173

Shares Held

36.7M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $232M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account